Jarislowsky, Fraser LTD Novo Nordisk A S Transaction History

Jarislowsky, Fraser LTD

  • $16.1 Billion
  • Q3 2024

A detailed history of Jarislowsky, Fraser LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 73,497 shares of NVO stock, worth $7.72 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
73,497
Previous 81,357 9.66%
Holding current value
$7.72 Million
Previous $11.6 Million 24.64%
% of portfolio
0.05%
Previous 0.08%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $935,890 - $1.14 Million
-7,860 Reduced 9.66%
73,497 $8.75 Million
Q2 2024

Aug 12, 2024
SELL
$122.71 - $146.91 $4.63 Million - $5.54 Million
-37,695 Reduced 31.66%
81,357 $11.6 Million
Q1 2024

Sep 30, 2024
SELL
$102.11 - $135.92 $477,874 - $636,105
-4,680 Reduced 3.78%
119,052 $15.3 Million
Q1 2024

May 13, 2024
SELL
$102.11 - $135.92 $477,874 - $636,105
-4,680 Reduced 3.78%
119,052 $15.3 Million
Q4 2023

Sep 30, 2024
BUY
$87.78 - $105.45 $3.72 Million - $4.47 Million
42,375 Added 52.09%
123,732 $12.8 Million
Q4 2023

Feb 12, 2024
SELL
$87.78 - $105.45 $838,299 - $1.01 Million
-9,550 Reduced 7.17%
123,732 $12.8 Million
Q3 2023

Sep 30, 2024
BUY
$90.94 - $199.54 $4.72 Million - $10.4 Million
51,925 Added 63.82%
133,282 $12.1 Million
Q3 2023

Nov 06, 2023
BUY
$90.94 - $199.54 $5.95 Million - $13.1 Million
65,451 Added 96.49%
133,282 $12.1 Million
Q2 2023

Sep 27, 2024
SELL
$155.98 - $172.65 $280,764 - $310,770
-1,800 Reduced 2.59%
67,831 $11 Million
Q2 2023

Jul 19, 2023
SELL
$155.98 - $172.65 $280,764 - $310,770
-1,800 Reduced 2.59%
67,831 $11 Million
Q1 2023

Sep 27, 2024
SELL
$132.34 - $159.14 $1.55 Million - $1.87 Million
-11,726 Reduced 14.41%
69,631 $11.1 Million
Q1 2023

May 11, 2023
SELL
$132.34 - $159.14 $260,048 - $312,710
-1,965 Reduced 2.74%
69,631 $11.1 Million
Q4 2022

Sep 27, 2024
SELL
$102.55 - $135.33 $1 Million - $1.32 Million
-9,761 Reduced 12.0%
71,596 $9.69 Million
Q4 2022

Feb 10, 2023
SELL
$102.55 - $135.33 $333,287 - $439,822
-3,250 Reduced 4.34%
71,596 $9.69 Million
Q3 2022

Nov 07, 2022
SELL
$95.28 - $116.93 $339,196 - $416,270
-3,560 Reduced 4.54%
74,846 $7.46 Million
Q2 2022

Jul 27, 2022
SELL
$103.24 - $121.81 $348,435 - $411,108
-3,375 Reduced 4.13%
78,406 $8.74 Million
Q1 2022

May 12, 2022
SELL
$93.1 - $112.54 $249,042 - $301,044
-2,675 Reduced 3.17%
81,781 $9.08 Million
Q4 2021

Feb 10, 2022
SELL
$95.88 - $117.08 $186,966 - $228,306
-1,950 Reduced 2.26%
84,456 $9.46 Million
Q3 2021

Nov 12, 2021
SELL
$84.42 - $106.62 $212,316 - $268,149
-2,515 Reduced 2.83%
86,406 $8.3 Million
Q2 2021

Aug 09, 2021
SELL
$67.66 - $84.76 $360,289 - $451,347
-5,325 Reduced 5.65%
88,921 $7.45 Million
Q1 2021

May 13, 2021
SELL
$67.06 - $75.82 $313,505 - $354,458
-4,675 Reduced 4.73%
94,246 $6.35 Million
Q4 2020

Feb 11, 2021
SELL
$63.89 - $73.8 $223,615 - $258,300
-3,500 Reduced 3.42%
98,921 $6.91 Million
Q3 2020

Nov 03, 2020
SELL
$63.69 - $70.22 $304,119 - $335,300
-4,775 Reduced 4.45%
102,421 $7.11 Million
Q2 2020

Aug 12, 2020
SELL
$58.54 - $67.94 $127,324 - $147,769
-2,175 Reduced 1.99%
107,196 $7.02 Million
Q1 2020

May 13, 2020
SELL
$49.46 - $64.78 $159,013 - $208,267
-3,215 Reduced 2.86%
109,371 $6.58 Million
Q4 2019

Feb 13, 2020
SELL
$49.86 - $58.26 $362,831 - $423,958
-7,277 Reduced 6.07%
112,586 $6.52 Million
Q3 2019

Nov 13, 2019
SELL
$47.54 - $53.43 $236,511 - $265,814
-4,975 Reduced 3.99%
119,863 $6.2 Million
Q2 2019

Aug 13, 2019
SELL
$46.79 - $52.47 $745,130 - $835,584
-15,925 Reduced 11.31%
124,838 $6.37 Million
Q1 2019

May 15, 2019
BUY
$46.36 - $52.63 $67,222 - $76,313
1,450 Added 1.04%
140,763 $7.36 Million
Q4 2018

Feb 01, 2019
SELL
$41.54 - $47.25 $75,768 - $86,184
-1,824 Reduced 1.29%
139,313 $6.42 Million
Q3 2018

Nov 14, 2018
SELL
$46.76 - $51.24 $58,169 - $63,742
-1,244 Reduced 0.87%
141,137 $6.09 Million
Q2 2018

Aug 10, 2018
BUY
$44.29 - $50.42 $60,588 - $68,974
1,368 Added 0.97%
142,381 $6.57 Million
Q1 2018

May 14, 2018
SELL
$48.49 - $58.14 $17,747 - $21,279
-366 Reduced 0.26%
141,013 $0
Q4 2017

Feb 13, 2018
SELL
$47.53 - $53.73 $270,825 - $306,153
-5,698 Reduced 3.87%
141,379 $0
Q3 2017

Nov 06, 2017
BUY
$41.15 - $49.22 $6.05 Million - $7.24 Million
147,077
147,077 $7.08 Million

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jarislowsky, Fraser LTD Portfolio

Follow Jarislowsky, Fraser LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email